The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study
Abstract
OBJECTIVES: To assess the incidence and spectrum of AIDS-defining opportunistic illnesses in the highly active antiretroviral therapy (cART) era. DESIGN: A prospective cohort study of 8070 participants in the HIV Outpatient Study at 12 U.S. HIV clinics. METHODS: We calculated incidence rates per 1000 person-years of observation for the first opportunistic infection, first opportunistic malignancy, and first occurrence of each individual opportunistic illness during 1994-2007. Using stratified Poisson regression models, and adjusting for sex, race, and HIV risk category, we modeled annual percentage changes in opportunistic illness incidence rates by calendar period. RESULTS: Eight thousand and seventy patients (baseline median age 38 years; median CD4 cell count 298 cells/microl) experienced 2027 incident opportunistic illnesses during a median of 2.9 years of observation. During 1994-1997, 1998-2002, and 2003-2007, respectively, rates of opportunistic infections (per 1000 person-years) were 89.0, 25.2 and 13.3 and rates of opportunistic malignancies were 23.4, 5.8 and 3.0 (P for trend <0.001 for both). Opportunistic illness rate decreases were similar for the subset of patients receiving cART. During 2003-2007, there were no significant changes in annual rates of opportunistic infections or opportunistic malignancies; the leading opportunistic illnesses (rate per 1000 person-years) were esophageal candidiasis (5.2), Pneumocystis pneumonia (3.9), cervical cancer (3.5), Mycobacterium avium complex infection (2.5), and cytomegalovirus disease (1.8); 36% opportunistic illness events occurred at CD4 cell counts at least 200 cells/microl. CONCLUSIONS: Opportunistic illness rates declined precipitously after introduction of cART and stabilized at low levels during 2003-2007. In this contemporary cART era, a third of opportunistic illnesses were diagnosed at CD4 cell counts at least 200 cells/microl.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Self-citationCastro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., & Curran, J. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.802 · Cited by 4,349
Palella, F. J., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., & Holmberg, S. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000233310.90484.16 · Cited by 1,350
Self-citationKaplan, J. E., Benson, C., Holmes, K. K., Brooks, J. T., Pau, A., & Masur, H. (2009) · PsycEXTRA Dataset · doi:10.1037/e537722009-001 · Cited by 1,343
Self-citationSurveillance for AIDS-Defining Opportunistic Illnesses, 1992–1997
Jones, J. L., Hanson, D. L., Dworkin, M. S., Alderton, D. L., Fleming, P. L., Kaplan, J. E., & Ward, J. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.8.897 · Cited by 819
Kaplan, J. E., Hanson, D., Dworkin, M. S., Frederick, T., Bertolli, J., Lindegren, M. L., Holmberg, S., & Jones, J. L. (2000) · Clinical Infectious Diseases · doi:10.1086/313843 · Cited by 705
Ledergerber, B., Egger, M., Erard, V., Weber, R., Hirschel, B., Furrer, H., Battegay, M., Vernazza, P., Bernasconi, E., Opravil, M., et al. (1999) · JAMA · doi:10.1001/jama.282.23.2220 · Cited by 481
AIDS across Europe, 1994–98: the EuroSIDA study
Mocroft, A., Katlama, C., Johnson, A., Pradier, C., Antunes, F., Mulcahy, F., Chiesi, A., Phillips, A., Kirk, O., & Lundgren, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02504-6 · Cited by 453
Natural history of HIV infection in the_era of combination antiretroviral therapy
Moore, R. D., & Chaisson, R. E. (1999) · AIDS · doi:10.1097/00002030-199910010-00017 · Cited by 443
Lewden, C., May, T., Rosenthal, E., Burty, C., Bonnet, F., Costagliola, D., Jougla, E., Semaille, C., Morlat, P., Salmon, D., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817efb54 · Cited by 342
Incidence of Opportunistic and Other Infections in HIV-Infected Children in the HAART Era
Gona, P., Van Dyke, R. B., Williams, P. L., Dankner, W. M., Chernoff, M. C., Nachman, S. A., & Seage, G. R. (2006) · JAMA · doi:10.1001/jama.296.3.292 · Cited by 279
Crum-Cianflone, N., Hullsiek, K. H., Marconi, V., Weintrob, A., Ganesan, A., Barthel, R. V., Fraser, S., Agan, B. K., & Wegner, S. (2009) · AIDS · doi:10.1097/qad.0b013e328317cc2d · Cited by 278
Sabin, C. A., Smith, C. J., Gumley, H., Murphy, G., Lampe, F. C., Phillips, A. N., Prinz, B., Youle, M., & Johnson, M. A. (2004) · AIDS · doi:10.1097/00002030-200411050-00006 · Cited by 218
Detels, R., Tarwater, P., Phair, J. P., Margolick, J., Riddler, S. A., & Muñoz, A. (2001) · AIDS · doi:10.1097/00002030-200102160-00008 · Cited by 187
Neuhaus, J., Angus, B., Kowalska, J. D., Rosa, A. L., Sampson, J., Wentworth, D., & Mocroft, A. (2010) · AIDS · doi:10.1097/qad.0b013e3283365356 · Cited by 178
Buchacz, K. A., Baker, R. K., Moorman, A. C., Richardson, J. T., Wood, K. C., Holmberg, S. D., & Brooks, J. T. (2008) · AIDS · doi:10.1097/qad.0b013e328304b38b · Cited by 139
Self-citationAntiretroviral Therapy Cohort Collaboration (ART-CC) (2009) · Clinical Infectious Diseases · doi:10.1086/597468 · Cited by 114
Gebo, K. A., Fleishman, J. A., & Moore, R. D. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000171727.55553.78 · Cited by 99
Trends in perimortal conditions and mortality rates among HIV-infected patients
Hooshyar, D., Hanson, D. L., Wolfe, M. I., Selik, R. M., Buskin, S. E., & McNaghten, A. D. (2007) · AIDS · doi:10.1097/qad.0b013e3282e9a664 · Cited by 87
Podlekareva, D. N., Mocroft, A., Dragsted, U. B., Ledergerber, B., Beniowski, M., Lazzarin, A., Weber, J. N., Clumeck, N., Vetter, N., Phillips, A. N., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/506366 · Cited by 79
Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France
Bonnet, F., Lewden, C., May, T., Héripret, L., Jougla, É., Bevilacqua, S., Costagliola, D. G., Salmon, D., Chêne, G., Morlat, P., et al. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510035328 · Cited by 77
Mocroft, A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.5.491 · Cited by 70
Bonnet, F., Chêne, G., Thiébaut, R., Dupon, M., Lawson‐Ayayi, S., Pellegrin, J., Dabis, F., Morlat, P., & (GECSA), F. T. G. D. C. D. S. E. A. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00508.x · Cited by 66
Phillips, A. N., Leen, C. L. S., Wilson, A., Anderson, J., Dunn, D. T., Schwenk, A., Orkin, C. M., Hill, T., Fisher, M., Walsh, J. C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61815-7 · Cited by 66
Effect of HAART on Incident Cancer and Noncancer AIDS Events Among Male HIV Seroconverters
Shiels, M. S., Cole, S. R., Wegner, S. A., Armenian, H. K., Chmiel, J. S., Ganesan, A., Marconi, V. C., Martínez-Maza, O., Martinson, J. J., Weintrob, A., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817dc42b · Cited by 36
Self-citationTeshale, E. H., Hanson, D. L., Wolfe, M. I., Brooks, J. T., Kaplan, J. E., Bort, Z., Sullivan, P. S., & Adult and Adolescent Spectrum of HIV Disease Study Group (2007) · Clinical Infectious Diseases · doi:10.1086/511862 · Cited by 23
Self-citationUse of Risk Equations for Predicting Disease Progression in HIV Infection
Mocroft, A., & Lundgren, J. D. (2009) · Clinical Infectious Diseases · doi:10.1086/597355 · Cited by 12
Cited by
Colonization by Pneumocystis jirovecii and Its Role in Disease
Morris, A., & Norris, K. A. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-12 · Cited by 429
Leeansyah, E., Ganesh, A., Quigley, M. F., Sönnerborg, A., Andersson, J., Hunt, P. W., Somsouk, M., Deeks, S. G., Martin, J. N., Moll, M., et al. (2013) · Blood · doi:10.1182/blood-2012-07-445429 · Cited by 372
Patel, P., Rose, C. E., Collins, P. Y., Nuche-Berenguer, B., Sahasrabuddhe, V. V., Peprah, E., Vorkoper, S., Pastakia, S. D., Rausch, D., & Levitt, N. S. (2018) · AIDS · doi:10.1097/qad.0000000000001888 · Cited by 270
Masur, H., Brooks, J. T., Benson, C. A., Holmes, K. K., Pau, A. K., & Kaplan, J. E. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu094 · Cited by 269
Self-citationTo, K., Cao, R., Yegiazaryan, A., Owens, J., & Venketaraman, V. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082541 · Cited by 264
Metadata
- Authors
- Buchacz, K., Baker, R. K., Palella, F. J., Chmiel, J. S., Lichtenstein, K. A., Novak, R. M., Wood, K. C., & Brooks, J. T.
- Venue
- AIDS
- Published
- 2010-06-19
- Volume
- 24
- Issue
- 10
- Pages
- 1549-1559
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2013979648
- Cited by
- 332
- References
- 28
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.